Launch plans rarely survive first contact with payers.
One immunology manufacturer learned this firsthand. Their internal strategy had a clear value story, aligned teams, and a rebate framework they believed would secure access.
Then they tested it with MAVA®.
- Launch was approaching fast.
- The team needed payer validation on their contracting model and evidence package.
- Waiting months for a traditional advisory board wasn’t possible.
They needed answers in days, not quarters.
With MAVA, In less than a week, the manufacturer:
- Gathered direct feedback from national and regional payers on rebate thresholds.
- Uncovered evidence gaps that could raise red flags in a P&T committee.
- Ran scenario modeling with Elasticity™ and Contracting ROI to see how different strategies would play out in the market.
All of it happened inside MAVA: a secure, digital environment designed to deliver insights at the speed of market access.
The results were decisive:
- The value story was reframed to emphasize payer-relevant endpoints.
- Contracting offers were restructured to balance rebates with margin protection.
- A potential launch misstep that would have eroded long-term value was avoided.
“The information we obtained from MAVA was enterprise-critical. The insights provided shifted our strategic direction for launch readiness.”
— Senior Director, Medical Payer Strategy
Market access moves faster than static plans. With MAVA, manufacturers don’t wait months for advisory boards, they pressure-test strategies with real payers in just five days.
Faster insight. Better outcomes. That’s MAVA in action.